Free Trial

Achieve Life Sciences (ACHV) News Today

Achieve Life Sciences logo
$4.18 +0.02 (+0.48%)
(As of 01:16 PM ET)
Achieve Life Sciences Appoints Mark K. Oki as CFO
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Average Recommendation of "Buy" by Analysts
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) has been given an average rating of "Buy" by the six research firms that are covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company.
Achieve Life Sciences Appoints Mark Oki As New CFO
Achieve Life Sciences, Inc. stock logo
Short Interest in Achieve Life Sciences, Inc. (NASDAQ:ACHV) Decreases By 9.6%
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 3,000,000 shares, a decline of 9.6% from the October 31st total of 3,320,000 shares. Based on an average daily trading volume, of 107,500 shares, the days-to-cover ratio is currently 27.9 days.
Achieve Life Sciences initiated with a Buy at Rodman & Renshaw
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences (NASDAQ:ACHV) Upgraded to Strong-Buy at RODMAN&RENSHAW
RODMAN&RENSHAW upgraded Achieve Life Sciences to a "strong-buy" rating in a research report on Thursday.
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences (NASDAQ:ACHV) Now Covered by Rodman & Renshaw
Rodman & Renshaw assumed coverage on shares of Achieve Life Sciences in a report on Thursday. They issued a "buy" rating and a $12.00 target price on the stock.
Achieve Life Sciences, Inc. stock logo
Equities Analysts Set Expectations for ACHV FY2024 Earnings
Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Equities research analysts at Zacks Small Cap reduced their FY2024 earnings per share (EPS) estimates for shares of Achieve Life Sciences in a research report issued on Monday, November 11th. Zacks Small Cap analyst J. Vandermosten now for
ACHV: Commercialization in Focus
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average - Time to Sell?
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving Average - What's Next?
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences (ACHV) to Release Earnings on Thursday
Achieve Life Sciences (NASDAQ:ACHV) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639706)
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?
Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200-Day Moving Average - Here's Why
Navy Mutual Goes Live with CalcFocus Forecast and Achieve
Achieve Life Sciences, Inc. stock logo
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving Average - Here's What Happened
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving Average - Should You Sell?
Achieve Life Sciences, Inc. stock logo
CVI Holdings LLC Cuts Stock Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV)
CVI Holdings LLC lowered its position in Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) by 87.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 71,749 shares of the biopharmaceutical company's stoc
Achieve Life Sciences Inc
Achieve Life Sciences, Inc. stock logo
Sofinnova Investments Inc. Cuts Holdings in Achieve Life Sciences, Inc. (NASDAQ:ACHV)
Sofinnova Investments Inc. lowered its stake in shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) by 8.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,388,372 shares of the biopharmaceutical company'
Get Achieve Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter.

The #1 Coin for November 2024 (Ad)

‘Gift’ Yourself a Potential 10,000% Win! #1 Crypto to Buy Before 2025 REVEALED!

Click here to get all the details on this crypto coin now.

ACHV Media Mentions By Week

ACHV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACHV
News Sentiment

0.89

0.55

Average
Medical
News Sentiment

ACHV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACHV Articles
This Week

0

3

ACHV Articles
Average Week

Get Achieve Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ACHV) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners